Insider cluster sells after a $108M offering are routine and likely liquidity-driven (vesting/blackout window). The minimal dollar proportion (0.04% of market cap) does not support a bearish read-through. Monitor for any pipeline news or upcoming clinical data that may have motivated the sales, but for now treat this as noise.
PHVS drugs
PHVS drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 21 $30.54entry
- T+1 · 6mo ago −2.82%α −3.26% · $29.68
- T+5 · 6mo ago −1.24%α −3.09% · $30.16
- T+20 · 5mo ago +8.07%α +7.74% · $33.01
- T+60 · 3mo ago +15.65%α +11.35% · $35.32
Price Chart
How similar events traded
Executive Summary
Four insiders at Pharvaris, including the CEO and Chief Commercial Officer, sold shares totaling $786K in open-market transactions over a 7-day window, closely following a $108M public offering completed on May 8. The cluster is predominantly selling, but the dollar amount is modest relative to the $2.0B market cap (~0.04%), and the asymmetric insider-selling literature indicates cluster sells are not reliably informative beyond the proportionality band. The cross-filing context with a recent offering is a known calibrative amplifier for this pattern, but the trivial proportionality keeps the signal low.
Key Financial Metrics
Key Facts
- Total insider sales: $786K across 4 insiders (CEO, CCO, CTO, Director)
- Sales occurred between May 15 and May 18, 2026, at ~$29.20–$29.92 per share
- CEO Berndt Modig sold 2,292 shares for $67K on May 18
- The cluster follows a $108M public offering (424B5) that closed May 8, 2026
- Sales represent ~0.04% of Pharvaris's $2.0B market cap
- Both principal deliveries (non-cash derivative exercises) accompanied the Director's sale; aggregate net cash to insiders is $786K
Financial Impact
$786K in insider sales over 7 days; 0.04% of $2.0B market cap
Risk Factors
- CEO selling even a small amount near $29 could indicate peak personal valuation if no later open-market purchases materialize
- If subsequent insider filings show additional material sales by the CEO or CFO without buys, the signal would modestly intensify
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-PHVS-1779312846156 |
Track record
51 reports on PHVS
15 of 18 bullish or bearish reports moved the stock their way by T+5. Best: +23.73% at T+20 after the Sep 17, 2026 report. 17 of 19 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 4/10 Entry $33.19 Now $32.44 −2.26% settles Nov 23
- Nov 13, 20263d ago SC 13G/A Bearish 5/10 Entry $33.59 Now $32.44 +3.42% settles Nov 23
- Nov 12, 20264d ago Press Release Bullish 7/10 Entry $33.83 Now $32.44 −4.11% settles Nov 19
- Nov 12, 20264d ago 6-K Neutral 4/10 No price data
- Nov 12, 20264d ago Press Release Neutral 5/10 Entry $33.83 Now $32.44 −4.11% settles Nov 19
- Sep 25, 20267w ago Insider Cluster Bearish 6/10 Entry $32.02 to $31.19 Now $32.44 −1.31% ▲ +2.59% +2.37% vs SPY
- Sep 24, 20267w ago Insider Cluster Bearish 7/10 Entry $32.99 to $31.01 Now $32.44 +1.67% ▲ +6.00% +5.59% vs SPY
- Sep 24, 20267w ago Insider Cluster Bearish 5/10 Entry $32.99 to $31.01 Now $32.44 +1.67% ▲ +6.00% +5.59% vs SPY
- Sep 23, 20267w ago Insider Cluster Bearish 6/10 Entry $33.07 to $31.72 Now $32.44 +1.91% ▲ +4.08% +3.41% vs SPY
- Sep 21, 20268w ago Insider Cluster Bearish 5/10 Entry $36.02 to $31.91 Now $32.44 +9.94% ▲ +11.41% +10.39% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers